Cingulate Shares Fall to 52-Week Low After Reverse Split

By Josh Beckerman Shares of Cingulate, which is developing drugs using its Precision Timed Release technology, fell to a 52-week low after a 1-for-20 reverse...

Related Keywords

Josh Beckerman ,Novartis ,Precision Timed Release ,Permanent Product Measure ,Article Normal ,Pharmaceuticals ,Anti Depressants ,Healthcare Life Sciences ,Specialized Drugs Medications ,Corporate Funding ,Share Capital ,Corporate Actions ,Corporate Industrial News ,Reverse Stock Splits ,Stock Splits Bonus Issues ,Equity Markets ,Commodity Financial Market News ,Content Types ,Factiva Filters ,C Amp Ampe Exclusion Filter ,C Amp Ampe Industry News Filter ,Synd ,Icing ,Us17248w2044 ,Corporate ,Industrial News ,Stock Splits ,Bonus Issues ,Commodity ,Financial Market News ,Healthcare ,Life Sciences ,Specialized Drugs ,Medications ,